Skip to main content

Table 2 Reasons for discontinuation of treatment

From: The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil

Reasons for discontinuation Number of patients,n (%)
Adverse Events 40 (18.5)
No reduction of 2 log viral load at week 12 3 (1.4)
Positive PCR qualitative at week 24 5 (2.3)
Withdrawal of the patients 3 (1.4)
Total discontinuation of treatment 51 (23.6)